Guru Ownership Trend
Guru Analysis for enGene Therapeutics Inc. (ENGN)
enGene Therapeutics Inc. (ENGN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.56 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $889,569.55 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 431.5%. Conversely, Steven Cohen reduced exposure by 91.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for enGene Therapeutics Inc. (ENGN)
Major holders include Renaissance Technologies (RenTech) ($1.44 M), Steven Cohen ($24,206). According to the latest reported data, 2 tracked investment managers collectively hold approximately 843,692 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $889,569.55, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ENGN. The total reported sell value was $275,758.45.
Yes, 0 managers opened new positions in ENGN, and 1 increased their existing holdings. The total reported buy value was $1.17 M.